Translational Medicine
Open Access

Editorial Note for Translational Medicine

Charles E Wade^{* *}Correspondence: Charles E Wade, Department of Surgery, The University of Texas Medical School, USA, Email:

Author info »

Dear Readers,

Journal “Translational Medicine” expresses sincere gratitude to all its elite panel of editorial board members for their continuous efforts, valuable support and encouragement throughout the publication journey of the journal, and the journal publish quality of research and becoming as one of the leading and well-recognized broadcaster of scientific outcomes in the field of studies related to findings developments from public health, global health policy planning and implementation research. The objective of TMCR is to publish highquality original research papers, survey reports, case studies, narratives, review article, short communication, clinical data, epidemiologic studies, thesis and relevant and insightful reviews. Every year we published with different volumes and different issues. Each issue of the journal covered with different types of topics in the field of molecular-diagnostics, personalizedmedicine, translational-medicine, discovering- novelbiomarkers, drug-delivery-andnanoparticle, translational-researchforcardiovascular-diseases, biomedical-research, translationalregenerative-medicine, moleculartargeted-therapies, molecularsignalling-andapoptosis. All published papers, are subject to the journal’s double-blind review process. The topics for the 2019 year were varied and exciting. The biggest category was probably TranslationalRegenerative-Medicine, but there is so much more involving scientists as academies and young researchers. The current volume of the journal is 10 with issue 1. The Timeline of processing from Submission to Publication is 45 days. Manuscripts will be published within 7 days of acceptance. The social media can play a key role in spreading the research work increased visibility, citation and ultimately the impact of published works. We promote published articles to the social media. This will benefit the researcher to increase reputation and attendant career progression. For example, the Facebook account, Twitter, LinkedIn and Instagram. According to the Google Analytics, more than 502,638 readers are visiting to our journal websites for submitting manuscripts, to browse the latest research published on public health and health issues and to refer the published content for conceptualizing their research study, deriving research hypotheses, case reports and validating their contributions. Readers from the major countries including United States, Japan, United Kingdom, India, Egypt and Nigeria visit our journal domain to learn about the ongoing research activities in this field. I take this opportunity to acknowledge the contribution of authors during the final editing of articles published and the support rendered by the editorial assistant in bringing out issues of TMCR in time. I would also like to express my gratitude to all the authors, reviewers, the publisher, the advisory and the editorial board of Journal Translational Medicine, the office bearers and staff for their support in bringing out yet another volume of TMCR and look forward to their unrelenting support to bring out the Volume 10 of TMCR in scheduled time.

Regards,

Editorial team

Translational Medicine

Whatsapp: +44-1235-425476

E-mail: transmed@emedicaljournals.org